Leishmania major promastigotes were found to avoid activation of mouse bone marrow-derived macrophages (BMMo) in vitro for production of cytokines that are typically induced during infection with other intracellular pathogens. Coexposure of BMMo to the parasite and other microbial stimuli resulted in complete inhibition ofinterleukin (IL) 12 (p40) mRNA induction and IL-12 release. In contrast, mRNA and protein levels for IL-lot, IL-113, tumor necrosis factor (TNF) ci, and inducible NO synthase (iNOS) were only partially reduced, and signals for IL-10 and monocyte chemoattractant protein (MCP-1/JE) were enhanced. The parasite could provide a detectable trigger for TNF-cx and iNOS in BMMo primed with interferon (IFN) y,
but still failed to induce IL-12. Thus IL-12 induction is selectively impaired after infection, whereas activation pathways for other monokine responses remain relatively intact. Selective and complete inhibition of IL-12(p40) induction was observed using BMMo from either genetically susceptible or resistant mouse strains, as well as IL-10 knockout mice, and was obtained using promastigotes from cutaneous, visceral, and lipophosphoglycan -deficient strains of Leishmania. The impaired production of the major physiologic inducer oflFN-y is suggested to underlie the relatively prolonged interval of parasite intracellular survival and replication that is typically associate with leishmanial infections, including those producing self-limiting disease. eishmania sp. are obligate intracellular protozoa that colonize macrophages in the vertebrate host, and their control requires the induction of immune responses capable of activating macrophages to a microbicidal state. The most potent cytokine for the induction of leishmanicidal activity in macrophages is IFN-y (1, 2). The sustained production of IFN-y in response to infection is commonly associated with the development of specific Thl and CD8 + T cell responses, whereas NK cells have been identified as an important, though more transient source of this cytokine (reviewed in reference 3). Parasites that are able to compromise the induction or function of IFN-y are undoubtedly favored for transmission since organisms able to attain high parasitemias and/or to persist in the vertebrate host will be more likely to encounter their phlebotomine vectors.
Considering the central role ofmacrophages in the initiation as well as effector functions of the immune response, infection of these cells might impair their ability to provide the appropriate regulatory cytokines for enhanced production of IFN-% Recent studies indicate that IL-12 plays an important role in potentiating cell-mediated immune responses during leishmanial infection. IL-12 is a heterodimeric cytokine produced primarily by monocytes, macrophages, and B cells, that stimulates growth of Thl and NK lymphocytes and induces synthesis oflFN-y by these cells (4) (5) (6) . In models of murine leishmaniasis, treatment of susceptible BALB/c mice with rlL-12 rendered these animals resistant to L. major by upregulating IFN-~/ and simultaneously inhibiting Th2 cytokine production (7, 8) . In vivo administration of IL-12 in mice also potentiated the efficacy of a killed vaccine for L. major (9) and provided effective therapy for an established systemic infection with L. donovani (10) . In vitro and in vivo experiments have demonstrated the crucial role of IL-12 in initiating and establishing both innate immunity and T cell-mediated resistance to other intracellular pathogens, including Toxoplasma gondii, Listeria monocytogenes, and Mycobacterium tuberculosis (11) (12) (13) (14) . Exposure ofmacrophages to these organisms results in strong induction oflL-12 in vitro. In contrast, L. major fails to elicit cytokine synthesis (including IL-12) by macrophages in vitro, (15) (16) (17) , and this has been suggested as an important strategy to delay the onset of strong IFN-~/production and macrophage activation during the early stages of infection (15) .
In the present studies, we ask whether cytokine responses by macrophages are induced, avoided, or actively impaired during in vitro infection with metacyclic promastigotes of different strains of Leishmania. O u r approach was to follow the kinetics of cytokine responses by bone marrow-derived macrophages (BMMo) 1 exposed to Leishmania promastigotes alone, or in combination with microbial stimuli k n o w n to activate cytokine gene expression by these cells. The responses examined included the proinflammatory cytokines IL-loL, IL-l[3, and TNF-oL; the monocyte chemoattractant protein (MCP-1/JE); inducible N O synthase (iNOS); and the immunomodulatory cytokines IL-12 and IL-10. O u r findings support the hypothesis that in contrast to other intracellular pathogens, Leishmania promastigotes fail to induce strong monokine responses generally, but that only the absence of IL-12(p40) m R N A expression and IL-12 release is due to an active and powerful inhibition of its induction. The selective impairment o f l L -12 induction might underlie the early progression but eventual control that is characteristic of leishmanial infections in the vertebrate host.
Materials and Methods
Macrophages. Female BALB/c, C3H/HeN, and C57BL/6N 036), mice 8-12-wk old, were obtained from the Division of Cancer Treatment, National Cancer Institute (Frederick, MD). The B6 IL-10-deficient (knockout) mice have been previously characterized (18) . BMMo were recovered following a previously published protocol (19) , with minor modifications. Briefly, femurs were flushed with HBSS containing 25 mM Hepes and 50 I~g/ml gentamycin sulfate, using a 27-in gauge needle. Bone marrow ceils were washed once and resuspended in DMEM supplemented with 10% HI-FCS, 30% L929 cefl-conditioned medium (source of M-CSF), 100 mM sodium pyruvate, 0.1 mM NEAA, 2 mM g-glutamine, 100 U/m1 penicillin, 100 mg/ml streptomycin, and 50 ~g/ml gentamycin. Differentiated MO were allowed to adhere overnight in 75 cm 2 culture flasks. Nonadherent cells were removed and plated (3 plates/mouse) in 3.5 cm polystyrene culture-treated petri dishes and incubated for 7 d at 37~ and 5% CO2. 1 d before infection, cells were washed twice and replenished with complete medium without L929 supernatants.
Parasites. L. major clone V1 (MHOM/IL/80/Friedlin) and L. donovani 1S strain (MHOM/SD/001S-2D) and its derived lipophosphoglycan (LPG)-deficient mutant, R2D2, (20) were cultured in 199 medium supplemented with 20% HI-FCS, 100 U/ml penicillin, 100 Ixg/ml streptomycin, 2 mM L-glutamine, 40 mM Hepes, 0.1 mM adenine (in 50 m/Vl Hepes), 5 btg/ml heroin (in 50% triethanolamine), and 1 ~g/ml 6-biotin (in 95% EtOH). In~Abbreviations used in this paper: BMMo, bone marrow-derived macrophages; HPRT, hypoxanthine-guanine phosphoribosyl transferase; iNOS, inducible nitric oxide synthase; LPG, lipophosphoglycan; MCP-I/JE, monocyte chemoattractant protein; Mtb, Mycobacterium tuberculosis; PKC, protein kinase C; STAg, soluble antigen from Toxoplasma gondii.
fective-stage promastigotes (metacyclics) of L. major were isolated from stationary cultures (5-6 d old) by their lack of agglutination by peanut agglutinin (PNA) (21) . The L. donovani promastigotes were obatined from unselected stationary cultures. Before infection, promastigotes were opsonized with 5% C5-deficient serum obtained from B10.D2/OsNj mice, by incubation at 37~ for 30 rain.
Macrophage Infections and Activation. For determination of cytokine responses in infected macrophages, parasites were used at a parasite/macrophage ratio of 20:1. LPS (Sigma Chemical Co., St. Louis, MO) was used in all the experiments at a concentration of 10 ng/ml. Recombinant mouse IFN-~ was used at 100 U/ml. Heat killed M. tuberculosis was kindly supplied by Drs. Patrick Brennan and Andrea Cooper (Colorado State University, Fort Collins, CO) and used at three different concentrations: 1,000, 100, and 10 bacteria/macrophage). Soluble antigen from T. gondii (STAg) was prepared as described (22) and used at 10 ~g/ml. The stimuli were either added to macrophages alone, or simultaneously with parasites for 2, 6, and 8 h before harvesting supernatants or addition of RNAzol for extraction ofmRNA.
mRNA Detection by RT-PCR. mRNA detection for the cytokines IL-llx, IL-113, TNF-o~, IL-10, and IL-12(p40), the [3-chemokine MCP-1/JE, iNOS, as well as a housekeeping gene, hypoxanthine-guanine phosphoribosyltransferase (HPRT), were performed using a semiquantitative R T -P C R method previously described (23) , with minor modifications. Briefly, at various times after incubation with parasites or stimuli, RNAzol was added directly to the petri dishes, and RNA extracted from the BMMo following the manufacturer's recommendations. 1 Ftg of RNA was reverse transcribed using Moloney murine leukemia virus reverse transcriptase (GIBCO BRL, Gaithersburg, MD). Samples were denatured at 70~ for 5 min before the addition of the enzyme and were then incubated 1 h at 60~ and 5 rain at 90~ to inactivate the enzyme. After cooling on ice for 3 rain, samples were diluted in distilled water to a final volume of 200 p~l (1:8) and stored at -20~ 10 ~1 of this solution was used for amplification in a semiquantitative PCR with Taq I Polymerase (Promega Corp., Madison, WI). Samples were incubated for 3 min at 95~ and were then amplified with an experimentally determined optimal temperature cycle number of (94~ for 1 min, 54~ for 1 rain, and 72~ for 2 min) for each cytokine mRNA. 24 cycles were used for HPRT, IL-lo~, IL-I~, TNF-~x, and JE; 35 for iNOS; 40 for IL-12(p40); and 30 cycles for IL-10. PCR products were Southern blotted, transferred to Hybond + membranes (Amersham Corp., Arlington Heights, IL), and probed with cytokinespecific fluorescein-labeled oligonucleotides. The enhanced chemiluminescent (ECL) detection system (Amersham Corp.) was used for detection, exposing the membranes to byperfilm (Amersham Corp.) at room temperature. The signals were analyzed using a densitometrical optical scanner (model 600ZS; Microteck, Torrance, CA) and Image software (National Institutes of Health, Bethesda, MD). Results were expressed as fold increase over control, considering the control value as one unit.
The primers and probes used for amplification and detection were as described for IL-hx, IL-113, and TNF-~x (23); for IL-10 and HPRT (24); for iNOS (22) and IL-12(p40) (25) ; and forJE (26) : HPRT: 5'-GTTGGATACAGGCCAAGACTTTGTTG; 3'-GAT-TCAACTTGCGCTCA-TCTTAGGC; probe GTTGTTGGAT-TGCCCTTGAC; IL-loc 5'-TGAGATTTTTAGAGTAACAGG; 3'-GGAAGATTGTCAAGAAGAGACGG; probe CCAGAT-CAGCACCTTACACC; IL-113: 5'-GGGATGATGATGATA-ACCTG; 3'-TTGTCGTTGCTTGGTTCTCCT; probe CAG-CTGCACTACAGGCTCCG; TNF-~x: 5'-CTCCAGCTGGA-AGACTCCTCCCAG; 3'-GATCTCAAAGACAACCAACTA-GTG; probe CCCGACTACGTGCTCCTCACC; iNOS: 5'-CTG-GAGGAGCTCCTGCCTCATG; 3'-GCAGCATCCCCTCT-GATGGTG; probe CTGGATGAGCTCATCTTTGCC; IL-12 p40: 5'-CGTGCTCATGGCTGGTGCAAAG; 3'-CTTCAT-CTGCAAGTTCTTGGGC; probe TCTGTCTGCAGAGAA-GGTCACA; IL-10: 5'-CGGGAAGACAATAACTG; 3'-CAT-TTCCGATAA.GGCTTGG; probe GGACTGCCTTCAGCC-AGGTGAAGACTTT; JE: 5'-TCAGCCAGATGCAGTTAACG; 3'-CAAGAAGGAATGGGTCCAGA; probe TCACCAGCAA-GATGATCCCAATGAG.
Cytokine Detection Assays. TNF-ot was determined by measuring the cytotoxicity to TNF-sensitive L929 cells of macrophage supematants recovered 6 h after infection and/or treatment (25) . Murine (Mu) rTNF-ot was used as standard. IL-12 was assayed in 6-h supernatants by a two-site RIA. Briefly, 96-well plates were coated overnight with 5 p~g/ml C15.1.2 Ab in sodium carbonate/bicarbonate buffer (pH 9.5). Plates were washed three times with PBS/0.05% Tween 20. Standard and samples were added to the plates, incubated overnight, washed again with PBS/Tween and incubated for 6 h with 12SI-labeled C15.6.7 Ab. Bound radioactivity was assessed by scintillation counting and the amount oflL-12 calculated by reference to a standard curve generated using rMulL-12 (Genetics Institute, Cambridge, MA). IL-1 was measured as described (27) weak but consistent signals for IL-10 andJE were observed at 2 h, declining to baseline by 6 h. These signals were no stronger when examined at 1 and 24 h (data not shown).
Effect of L. major Infection on LPS-and Mtb-induced BMMo Activation. The effect of leishmanial infection on either
LPS-or Mtb-induced m R N A expression in B M M o from BALB/c mice was examined in separate experiments at 6 h after treatment for IL-lcx, IL-1]3, TNF-ot, iNOS, and IL-12(p40), and at 2 h for IL-10. Again, the parasite alone induced no detectable proinflammatory cytokine m R N A , except for very weak expression of TNF-er (Fig. 2) . In contrast, parasite activation of IL-10 message was relatively strong in these experiments. LPS and Mtb, at each of the three doses tested, induced strong expression of all cytokine genes, with the exception of IL-10, which was only weakly expressed after 2 h in response to LPS. The effect of the parasite on these responses was a partial inhibition of IL-l(x, IL-1[3, TNF-(x, and iNOS, a strong inhibition of IL-12(p40), and potentiation of lL-10. The IL-12(p40) response to LPS was completely inhibited, as was the IL-12(p40) response to the lowest concentration of Mtb. The opposite effects that the promastigotes had on IL-12(p40) and IL-10 m R N A induction are more quantitatively represented in Fig. 3 , which, after normalizing for input R N A , confirms the virtually complete inhibition of the IL-12(p40) response to LPS and lower doses of Mtb, and reveals in addition a strong inhibition of the response to even the highest concentration of Mtb. The upregulation of IL-10 is significant at the lower doses of Mtb.
L. major Promastigotes Evade Cellular Activation of BMMo from Genetically Resistant As Well As Susceptible Mouse Strains.
The differential effects that the parasite has on cytokines known to regulate the development of distinct CD4 + T cell subsets suggested a possible mechanism to explain the preferential activation of Th2 ceils that occurs in response (Fig. 4) . IL-10 m R N A also was not detected, although in these experiments only the 6-h time point was analyzed. Low levels of parasite-induced transcripts for JE were detectable in cells from BALB/c and B6 mice. The effects of the parasite on LPS-and Mtb-induced responses were also similar in the three mouse strains. Slight inhibition of IL-l~x and TNF-o~ was accompanied by complete inhibition of both LPS-and Mtb-induced IL-12(p40) expression in all three mouse strains. Upregulation of IL-10 and JE also occurred in the three mouse strains.
The levels ofIL-lci, TNF-or and IL-12 contained in the B M M o culture supernatants were also determined for the three mouse strains (Table 1) . TNF-oL and IL-12 were measured in 6-h supernatants from the same cells used for m R N A analyses. Reliable assay of IL-1 required longer incubation, and was determined from a separate experiment in which supernatants were harvested at 18 h. The protein levels closely reflected the pattern of m R N A expression determined by R T -P C R . LPS and Mtb elicited good production of the three cytokines by cells from all three mouse strains. These cytokines were not detectable in supernatants from the cells exposed to L. major promastigotes alone, save for the relatively high levels of IL-lcx/[3 produced by the infected cells from C3H mice. Furthermore, the parasite completely inhibited (to background levels) the LPS-and Mtb-induced IL-12 production by cells from all three mouse strains. In contrast, TNF-o~ production was only reduced by half or not at all, and IL-1 production was actually enhanced, again with comparable effects observed in all three mouse strains. Thus the selective effects that the parasite has on IL-12(p40) gene expression and production seem n o t to be related to the l o n g -t e r m o u t c o m e of infection in these mouse strains.
Leishmania Promastigotes Evade Triggering IL-I2 Production in BMMo Primed with IFN-T.
Macrophages are considered fully activated w h e n they receive both "priming" and "triggering" stimuli, which in experimental systems typically have been provided by I F N -y and LPS, respectively (28) . If the parasite's inability to activate macrophages for cytokine expression were due to defects confined largely to macrophage priming, then provision of this signal might reveal a triggering stimulus associated with infection. This 519 Carrera et al. sponses, the parasite can provide a measurable stimulus so long as the cells are adequately primed. In contrast, priming with I F N -y had no effect on the IL-12(p40) response to the parasite, which remained undetectable. The protein data for this experiment is shown in Table 2 . Priming with IFN-2r increased IL-12 production induced by LPS, Mtb, and STAg by approximately twofold. The IL-12 produced in response to L. major promastigotes remained at background levels even in the presence of IFN-'y. Preexposure of the B M M o to I F N -y for 18 h before as well as during infection still failed to induce IL-12 (data not shown). The ability of IFN-3, to upregulate TNF-ot production was apparent only for the response to Mtb, although the biological assay failed to detect TNF-tx released in response to those stimuli for which the m R N A signals were weak.
The Downregulation of lL-12 Induction by L. major Promastigotes Is Not IL-IO Dependent. IL-10 was originally de-
scribed as a factor produced by Th2 cells that inhibited the synthesis of cytokines by T h l cells (30) . It has since been shown to be produced by other cell types, including Ly-1 B cells, mast cells, and macrophages, and its effects on I F N -y production have been shown to be through an inhibition of macrophage accessory cell function rather than a direct interaction with IFN-',/-producing cells (31) . IL-10 has been found to inhibit the production of proinflammatory cytokines by macrophages, including TNF-tx, IL-1, IL-6, and IL-12 (32) . As IL-10 m R N A expression was stimulated early in infection (2 h) by L. major promastigotes, and its induction by LPS or Mtb was also upregulated by the parasite, the possibility that IL-10 might be responsible for the downregulation of IL-12 synthesis during infection was assessed by analysis oflL-12(p40) mR.NA induced in B M M o from IL-10 knockout C57BL/6 mice (Fig. 6 ). The lack of detectable IL-10 transcripts in the activated cells from the knockout mice is consistent with the fact that the 5' primer sequence used to amplify IL-10 c D N A binds within the first exon, which has been replaced by a neomycin gene in the knockout mice (18) . In both the knockouts and the wild-type controls, no IL-12(p40) m R N A was seen in response to the parasite alone, and in both strains the LPSand Mth-induced expression of the gene was strongly inhibited by the parasite (Fig. 6) . The apparent greater intensity of the residual IL-12(p40) signals observed in the knockout cells was found to be comparably reduced when normalized and expressed as fold increase over control. The lack of any difference between the strains is reinforced by the IL-12 levels in the culture supernatants. For the wildtype cells, LPS-and Mtb-induced IL-12 production was reduced by the parasite from 2,892 and 1,413 pg/ml, respectively, to 263 and 202 pg/ml. However, for the IL-10 knockout cells, the values for IL-12 were reduced from 3,982 and 2,300 pg/ml to 165 and 97 pg/ml.
The Ability of Promastigotes to Inhibit IL-12 Activation Is Not Dependent on Expression of the Abundant Surface Lipophosphoglycan. LPG is the major surface glycoconjugate of
Leishmania promastigotes and has been implicated in the downregulation of protein kinase C (PKC)-mediated signal transduction in macrophages (33) . To determine whether LPG plays a role in the inhibition of activation signals leading to IL-12(p40) expression, the Mtb-induced mtLNA responses in B M M o from BALB/c mice were examined in the presence of stationary phase promastigotes of L. major, L. donovani, and an LPG-deficient mutant of L. donavani, termed P,2D2. The effects of these parasites on cytokine gene expression were similar in each case (Fig. 7) . The responses induced by the parasites themselves were negligible, save for the low expression of TNF-ot. Their inhibitory effects on Mtb-induced IL-1, TNF-oL, and iNOS expression were slight in each case (the absence of an iNOS signal was not observed in a subsequent experiment), whereas each was able to completely inhibit expression oflL-12(p40). Finally, each strain was able to significantly upregulate the IL-10 response. Thus, the requirement for LPG in the differential effects on cytokine gene expression can be ruled out, although the data do not preclude a requirement for glycolipids structurally related to LPG which are still expressed by the R.2D2 mutant. 
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Discussion
Cells of the macrophage lineage play a pivotal role in the development of immune responses to microorganisms, in part through the processing of microbial antigens for presentation to T cells, through the expression of cell surface costimulatory molecules, and through the release of immunoregulatory cytokines. The ability of infected macro- phages to present leishmanial antigens to T cells and to drive their activation is well supported (34) (35) (36) . The present data argue that infected macrophages will drive early T cell activation in the absence of IL-12, thereby avoiding the major physiologic inducer for Thl development, elevated production of IFN-% and activation of macrophages to a microbicidal state. The findings are essentially in agreement with those of R, einer et al. (15) , who proposed that Leishmania promastigotes avoid initiating activation signals for inflammatory and immunodulatory cytokines generally, and IL-12 in particular, and in this way the survival of the parasite in the vertebrate host is prolonged. The present studies extend these observations by demonstrating that whereas the attachment to and entry of Leishmania promastigotes into macrophages proceeds in a remarkably silent manner, of the various cytokine responses examined, only the induction of IL-12(p40) was found to be actively impaired.
Infection of BMMo with serum-opsonized L. major metacyclic promastigotes failed to induce detectable levels of m R N A for most of the cytokine genes studied. Weak but positive signals for IL-10 and JE were consistently observed, especially when the response was examined early. Infection of BMMo during exposure to microbial stimuli known to initiate strong activation signals resulted in three general effects: (a) strong, and in most cases, complete inhibition of IL-12(p40) m R N A and protein synthesis; (b) partial, and in most cases, weak inhibition of mP,.NA and/or protein for IL-tx, IL-lJ3, TNF-~x, and iNOS; and (c) upregulation of mIkNA for IL-10 and MCP-1/JE. These outcomes suggest that IL-12 production is tightly regulated by an activation pathway(s) that is selectively and efficiently compromised by Leishmania promastigotes during infection. The involvement of several alternative induction pathways for TNF-0t and IL-~ (28, 37, 38) suggests a basis for the partial inhibition of these cytokines during leishmanial infection, in which only the pathway(s) common to IL-12(p40) induction might be impaired.
Selective inhibition of IL-12 synthesis was also observed when BMMo were treated with IFN-% which revealed that the parasite could provide a detectable stimulus for TNF-ix and iNOS gene expression in primed cells, but still failed to provide a trigger for IL-12. In contrast, exposure of the cells to LPS, killed Mtb, or STAg during priming with IFN-',/ resulted in significantly upregulated synthesis of TNF-o~, iNOS, and especially IL-12. The ability of Leishmania-infected cells to be activated by IFN-~ for intracellular killing, either alone or in combination with other stimuli, is well described (1, 2, 29) . The data suggest that the inability of the parasite to induce certain cytokines during infection is due less to the fact that relevant induction pathways are disrupted than to the fact that the parasite alone is unable to provide both the priming and triggering stimuli required for their expression. Other investigators have reported that even primary exposure of macrophages to Leishmania, either amastigotes or promastigotes, results in release of significant levels of IL-1 or TNF-o~ (27, 29, 39, 40) . It is not clear why in our studies and that of others (41) the parasite alone failed to stimulate production of these cytokines, although differences in the subpopulation of the macrophages used and/or LPS contamination are possible explanations. These data, nonetheless, reinforce the conclusion that Leishmania-infected cells retain the potential to produce most of the cytokines involved in inflammatory and effector functions, including those mediated by IFN-~/.
The reciprocal effects that the parasite has on IL-12 and IL-10 production by BMMo does not seem to explain the preferential activation of Th2 cells during infection of genetically susceptible BALB/c mice, since identical outcomes were observed using BMMo from resistant C57BL/6 and C3H mice. In addition, these effects were not confined to Leishmania species with particular clinical associations, since they were seen using both L. major and L. donovani promastigotes. The avoidance of IFN-~ induction pathways might, instead, underlie the relatively prolonged duration of parasite survival and amplification that is characteristic of leishmanial infections generally, whether they be self-healing or progressive, cutaneous or visceral. Unlike the rapidly self-limiting infections produced by other intracellular pathogens, such as Mycobacteria, Listeria, Cryptosporidia, or Toxoplasma, the self-limiting infections caused by Leishmania require weeks or months to resolve. Leishmania strains able to amplify their numbers by delaying the onset of host control mechanisms clearly will be favored for transmission. This may be especially true for parasites producing localized cutaneous or mucosal disease, which will have infrequent encounters with their phlebotomine vectors.
There is considerable evidence that the delayed onset of heating typically seen in self-limiting forms of leishmanial disease is due to the slow development of cell-mediated immune response (i.e., delayed production of IFN-~), rather than, as has been suggested (42), the inability of infected cells to be activated for killing (that is, impaired response to IFN-~/). For example, patients are susceptible to reinfection during the active stages of cutaneous disease, whereas they are resistant after healing has commenced (43, 44 , and reviewed in reference 45). Experimentally, evidence for defective IL-12 induction by Leishmania is suggested by studies in scicl mice, which are capable of producing a T cell-independent, IL-12-dependent IFN-~/response to a variety of intracellular bacteria and parasites, including L. monocytogenes, Corynebacterium parvum, Salmonella, Mycobacteria, and T. gondii (12, 25, 46) . In contrast, L. donovani promastigotes failed to initiate an NK cell-derived IFN-~/ response in spleen ceils from scid mice, either in vivo or in vitro (47) .
Direct evidence for delayed induction of IL-12(p40) transcripts during L. major infection was reported by Reiner et al. (15) for both susceptible and resistant mouse strains). In addition, anti-IL-12 antibodies could be administered to C57BL/6 mice as late as 2 wk after infection and still exacerbate disease, consistent with delayed production of IL-12 (48) . In more recent studies (49, 50) , delayed production of IL-12 in response to L. major was confined to C57BL/6 mice, whereas C3H and, surprisingly, BALB/c mice, produced an elevated IL-12 response within 1 d of infection. Whereas the early C3H response was associated with rapid control of the parasite, the delayed response in C57BL/6 mice was associated with larger lesions requiring longer to heal. For BALB/c mice, the induction of Thl cells and elevated levels of IFN-~/ by IL-12 was thought to be prevented by the simultaneous production of inhibitory cytokines.
To what extent do the in vitro outcomes using BMMo grown in M-CSF conditioned medium and used after 6-7 d of adherence, which represent relatively heterogeneous populations of differentiated cells, reflect the in vivo experience with high doses of subcutaneously inoculated parasites? The response of BMMo to infection is certainly consistent with the in vivo outcomes in C57BL/6 mice, which arguably model most closely the course of cutaneous leishmaniasis in natural hosts. In contrast, the early IL-12 response in C3H and BALB/c mice might be explained by strain polymorphisms in the number and tissue distribution of distinct macrophage subpopulations, or cell types such as B cells, keratinocytes or neutrophils, that are each capable of producing IL-12, but that might respond quite differently to the parasite or its products. Recent observations bear indirectly on this point. When leishmanial antigens were presented by GM-CSF-derived macrophages as opposed to M-CSF macrophages, they were able to induce high levels of IFN-3' and resistance to infection in BALB/c mice (51) . There is growing evidence from in vitro studies that differences in antigen-presenting cell populations can influence the pattern of CD4 + subset development (52) . The ability of a high dose inoculum to stimulate an early IL-12 response in certain mouse strains may reflect events which are more typically delayed during infection in C57BL/6 mice and natural hosts. As the parasite load increases, the parasite or its products might no longer be confined to the same cell types targeted by metacyclic promastigotes at the initiation of infection, such that different patterns of regulatory cytokines emerge.
Although IL-10 was first described as a cytokine that inhibits macrophage-dependent cytokine synthesis by Thl cells (30) , it does not appear to be involved in downregulating IL-12 synthesis by infected macrophages since cells from IL-10 knockout mice still failed to produce IL-12 in response to promastigotes, and were also markedly inhibited by the parasite for expression of LPS-and Mtbinduced IL-12(p40) transcripts and protein. It is possible that IL-10 production by infected cells might impair other accessory cell functions. IL-10 has been found to downregulate expression of B7 and other costimulatory surface molecules (53) , and this might be related to the recent observation that B7 is downregulated on Leishmania-infected cells (54) . Furthermore, since B7/CD28 interactions synergize with IL-12 to induce high levels ofIFN-~/(55, 56), the coordinate inhibition of both molecules, whether by related or independent mechanisms, might ensure that IFN-~/ induction pathways are avoided. The previously unreported possibility that the parasite can directly activate an IL-10 response in macrophages, might explain the source of IL-10, which has been found to be associated with certain chronic leishmanial infections (57, 58) , especially since other Th2-associated cytokines were not also seen.
The possible role of TGF-[3 in IL-12 downregulation has not been investigated in these studies but should be considered, given the ability of this mediator to potentiate Leishmania intramacrophage survival in vitro and in vivo (59, 60) . TGF-[3 is a suppressor of many known macrophage responses, including the oxidative burst (61), microbicidal response to IFN-~/ (59), as well as IL-12-initiated IFN-~/production by human neonatal CD4 + cells (62) . Its pleiotropic activities may not, therefore, be consistent with the selective effects that the parasite has on IL-12. Furthermore, TGF-[3-mediated suppression ofLPS-induced TNF-e~ and IL-1 release by macrophages was found to be late acting (12-16 h; 63); this is not consistent with the defects associated with IL-12(p40) induction in infected cells.
The alternative to agonist-mediated suppression of IL-12 induction is that the parasite or its products directly interfere with specific signal-transducing events. There is substantial evidence that leishmanial infection selectively impairs PKC-dependent signal transduction in host macrophages (64, 65) , suggesting that this may be an essential pathway for induction of IL-12. Leishmania-infected cells or macrophages treated with promastigote LPG display defective membrane translocation of PKC or defective phosphorylation of endogenous PKC substrates, respectively. It is clear that since the LPG-deficient mutant, R2D2, was as inhibitory for IL-12 induction as the wild-type strain, LPG is not required for this effect. This result does not rule out the possible role of LPG-related structures, that is, the glycosylinositolphospholipids (66) , which are still abundantly expressed by R2D2. The involvement of PKC-dependent signal transduction in IL-12 upregulation and its specific disruption by the parasite are currently being explored.
